Efficacy and safety of everolimus for patients with focal cortical dysplasia type 2

Efficacy and safety of everolimus for patients with focal cortical dysplasia type 2

Abstract Objective This study aimed to evaluate the effectiveness and safety of everolimus in treating seizures associated with focal cortical dysplasia type 2 (FCD 2). Methods A prospective, crossover, placebo‐controlled clinical trial (ClinicalTrials.gov: NCT03198949) enrolled patients aged 4–40 y...

Full description

Saved in:
Bibliographic Details
Main Authors: Se Hee Kim, Hoon‐Chul Kang, Yun Ho Roh, Jongsung Hahn, Kyung Lok Min, Seok‐Jin Lee, Donghwa Yang, Han Som Choi, Soyoung Park, Jeong Ho Lee, Sang‐Guk Lee, Se Hoon Kim, Min Jung Chang, Heung Dong Kim
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Epilepsia Open
Subjects:
epilepsy
drug‐resistant epilepsy
Everolimus
focal cortical dysplasia
MTOR inhibitors
Online Access:https://doi.org/10.1002/epi4.13104
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/epi4.13104

Similar Items